subject area of
- An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report Academic Article
- Antimanic Response to Aripiprazole in Bipolar I Disorder Patients Is Independent of the Agitation Level at Baseline Academic Article
- Aripiprazole Augmentation in the Treatment of Military-Related PTSD with Major Depression: a retrospective chart review Academic Article
- Aripiprazole Reduces Alcohol Use Academic Article
- Aripiprazole-Associated QTc Prolongation in a Geriatric Patient Academic Article
- Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis Academic Article
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations Academic Article
- Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report Academic Article
- Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report Academic Article
- Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study Academic Article
- Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study Academic Article
- Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report Academic Article
- In older adults with treatment-resistant depression, adding aripiprazole to venlafaxine increased remission at 12 wk Academic Article
- Interactions between neuroticism and stressful life events predict response to pharmacotherapy for major depression: A CAN‐BIND 1 report Academic Article
- Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats Academic Article
- Pain severity and pain interference during major depressive episodes treated with escitalopram and aripiprazole adjunctive therapy: a CAN-BIND-1 report Academic Article
- Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report Academic Article
- Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy Academic Article
- Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression Academic Article
- Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder Academic Article
- Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder Academic Article